Bone Support

Osteoporosis is the most common metabolic bone disease in the United States, affecting as much as 50 percent of the population over the age of 65. Osteoporosis results in more than six million spontaneous fractures annually. These, particularly of the hip, can have devastating consequences, contributing to considerable pain, suffering, and loss of life. Treatment for osteoporosis is now more than just calcium supplementation. Extensive human studies show that Ipriflavone not only helps slow the rate of bone loss, it enhances bone density and decreases fracture risk.